Real-world management of relapsed/refractory MM in China is highly variable. These findings highlight the necessity for ongoing research and evidence-based guidelines to optimize patient outcomes.
Building similarity graph...
Analyzing shared references across papers
Loading...
D. Wu
Bhavna Murali
Otávio Clark
Future Oncology
Pfizer (United States)
First Affiliated Hospital of Xi'an Jiaotong University
Oracle (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...
Wu et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69df2c50e4eeef8a2a6b15a4 — DOI: https://doi.org/10.1080/14796694.2026.2656394